MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Dermatology

MedScape 06 September at 04.21 PM

Not Kidding: Yellow Dye 5 May Be the Key to Invisibility

A common food dye turned mice see-through, a "stunning" finding that could revolutionize imaging techniques in medicine.

MedScape 06 September at 10.10 AM

Vitiligo: Combination Therapies and Emerging Treatments

It can take up to 1 year to see a significant response with topical immunosuppressants and narrowband ultraviolet B treatment.

MedScape 06 September at 09.06 AM

Metformin May Help Manage Scarring Alopecia, Study Suggests

Low-dose oral metformin was associated with symptomatic improvement, hair regrowth, and gene expression modulation in a case series of patients with treatment-refractory central centrifugal cicatricial alopecia.

MedScape 05 September at 09.33 AM

Study Finds Skin Cancer Risk Increased in US Veterans

The risk for any skin cancer was higher among US veterans than among nonveterans, according to a cross-sectional study using nationally representative data collected over 20 years.

MedScape 05 September at 02.48 AM

How Do Tapinarof, Roflumilast Creams Fit Into Psoriasis Rx?

Both nonsteroidal options are fast-acting, Jashin J. Wu said.

HealthDay 04 September at 03.03 PM

Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 Genotype

The association of prenatal ω-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) with the risk for childhood atopic dermatitis (AD) varies based on the maternal cyclooxygenase-1 (COX1) genotype, according to a study published online Aug. 28 in JAMA Dermatology.Liang Chen, from Herlev and Gentofte Hospital in Copenhagen, Denmark, an

MedScape 04 September at 05.35 AM

Study Characterizes Skin Toxicity With Uveal Melanoma Rx

Nearly 80% of patients with uveal melanoma treated with tebentafusp experienced skin reactions in a small cohort study.

MedScape 04 September at 03.17 AM

Topical Timolol an Option for Treating Pyogenic Granuloma

Several case reports about the use of topical timolol for PG have been published in the medical literature, including a case series.

HealthDay 03 September at 08.05 PM

Global Study Reveals Widespread Micronutrient Deficiencies

More than 5 billion people globally do not consume enough iodine, vitamin E, and calcium, according to a study published online Aug. 29 in The Lancet Global Health.Simone Passarelli, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues estimated micronutrient intake using a novel approach accounting for t

MedScape 02 September at 09.11 AM

Study Assesses Childhood Cancer Survivors' Risk for KCs

This study "provides the largest longitudinal profile" of keratinocyte carcinomas in childhood cancer survivors to date, according to the authors.

MedScape 02 September at 08.43 AM

Can Prenatal Fish Oil Reduce AD Risk in Children?

The mother's COX1 genotype could influence whether prenatal fish oil supplementation affects the risk for atopic dermatitis in children, a study found.

MedScape 02 September at 04.21 AM

Vitiligo Linked to Psychiatric Conditions in Black Children

A study found a significantly higher risk for several psychiatric disorders in Black children with vitiligo.

HealthDay 30 August at 03.06 PM

Dietary Vitamin E May Be Protective Against Atopic Dermatitis

Dietary intake of vitamin E may potentially lower the risk for atopic dermatitis, according to a study published online Aug. 9 in Skin Research & Technology.Siqing Wang, from the Beijing University of Chinese Medicine, and colleagues conducted a Mendelian randomization analysis to explore the causal relationship between dietary

MedScape 30 August at 02.38 AM

Impact of Neurofibromatosis on Quality of Life Evaluated

A crowdsourced registry study found associations between features of cutaneous neurofibromas and quality of life in patients with neurofibromatosis type 1.

MedScape 30 August at 01.40 AM

Laser Treatment for Acne: Results From 100 Patients

The protocol included three laser treatments spaced 3-4 weeks apart combined with medical therapy and other energy-based devices.

HealthDay 29 August at 03.46 PM

People With Xylazine Wounds Face Barriers to Seeking Wound Care

People with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in Drug and Alcohol Dependence.Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to und

HealthDay 27 August at 09.50 PM

Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time

Physicians who adopt team-based documentation, defined as use of coauthored documentation with another clinical team member, experience increased visit volume and reduced documentation time, according to a study published online Aug. 26 in JAMA Internal Medicine.Nate C. Apathy, Ph.D., from the University of Maryland School of Public He

HealthDay 27 August at 03.52 PM

Childhood Obesity Tied to Pediatric Immune-Mediated Skin Diseases

Early childhood obesity may increase the risk for pediatric immune-mediated skin diseases, according to a study published online Aug. 21 in the Journal of Investigative Dermatology.Seong Rae Kim, M.D., from the Seoul National University College of Medicine in South Korea, and colleagues examined associations between body mass inde

MedScape 26 August at 07.36 AM

iPLEDGE Reforms: Are Changes Imminent? Timeline Unclear

The timeline for when an improved program might be in place remains unclear.

MedScape 26 August at 06.44 AM

TYK2 Inhibitor Shows Promise for Moderate, Severe Psoriasis

Zasocitinib showed significant efficacy in treating moderate to severe psoriasis, with 67%-68% of patients on higher doses achieving a PASI 75 score at 12 weeks.

MedScape 22 August at 11.33 PM

Quitting Smoking Reduces HS Risk After 3 Years

Smoking cessation reduced the risk for hidradenitis suppurativa, eventually aligning with the risk for never smokers.

HealthDay 22 August at 09.33 AM

Americans Have Mixed Feelings About AI in Health Care, Poll Finds

Most Americans believe artificial intelligence should be used to improve health care, a new national survey reports.However, many are still a little queasy over some of the implications of widespread AI use, the <a href="https://wexnermedical.osu

HealthDay 21 August at 03.11 PM

Collagen Peptide Beverage Beneficial for Skin Health in Young Women

A beverage containing collagen peptides (CP), including tripeptides and elastin peptides (EP), is beneficial for the skin health of young and middle-aged women, according to a study published in the June issue of the Journal of Dermatologic Science and Cosmetic Technology.Shan Lu, from the Shenzhen Porshealth Bioengineering Co. in Ch

MedScape 21 August at 12.26 PM

Laser Treatment of Nonmelanoma Skin Cancer on the Rise

A seminal study from 2017 laid the groundwork for current approaches, Elizabeth Tanzi, MD, said.

MedScape 20 August at 05.00 AM

Dermatologist Offers Best Practices for Social Media Posts

Deciding which platforms to use and what voice or tone to adopt requires some soul-searching, according to Jessica G. Labadie, MD.

MedScape 19 August at 06.04 AM

Who's Performing Cosmetic Procedures at MedSpas?

The top two procedures performed by the surveyed MedSpas are facials and hair removal.

HealthDay 16 August at 09.21 PM

Skin of Color Has More Adverse Events From Sclerotherapy

Patients with skin of color may experience more adverse events from sclerotherapy, according to a study published online July 26 in the&nbsp;Journal of the American Academy of Dermatology.Michelle Lazar, from the Boston University School of Medicine, and colleagues characterized the incidence of common adverse events following sclerothe

MedScape 16 August at 07.49 AM

Managing Orofacial Changes in Scleroderma

The recommended treatment for patients with scleroderma was to use nerve blocks for injecting HA filler or hyaluronidase and to minimize the injection points.

HealthDay 15 August at 10.00 PM

FDA Approves Nemluvio for Prurigo Nodularis

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosi

HealthDay 14 August at 03.45 PM

Clinicians Are Interested in Climate Change Education

Most clinicians show positive attitudes toward education in climate change, according to a study published online Aug. 8 in&nbsp;JAMA Network Open.Wynne Armand, M.D., from the Center for the Environment and Health at Massachusetts General Hospital in Boston, and colleagues evaluated whether a quality incentive program measure for cli

MedScape 14 August at 11.00 AM

Alopecia: What Happens When Baricitinib Responders Stop Rx?

Continuous treatment with baricitinib is needed to maintain hair regrowth in patients with severe alopecia areata.

MedScape 14 August at 11.00 AM

Dermatomyositis: Age at Dx, Signs Differ in Hispanics

A study identified distinct clinical features and other differences in Hispanic patients with dermatomyositis compared with non-Hispanic patients.

MedScape 13 August at 11.30 AM

FDA Approves Nemolizumab for Prurigo Nodularis

The interleukin-31 inhibitor is also under FDA review for treating atopic dermatitis.

MedScape 13 August at 08.21 AM

Recommendations on Managing Cutaneous Side Effects of ICIs

Cutaneous immune-related adverse events (cirAEs) are the most frequently reported and most visible adverse effects of checkpoint inhibition.

HealthDay 12 August at 03.54 PM

Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With Eczema

For patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a study published online Aug. 7 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined clini

HealthDay 12 August at 03.47 PM

Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma Patients

A gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab, according to a study published online Aug. 8 in Clinical Cancer Research.Kelsey R. Monson, Ph.D., from the Perlmutter Cancer Center at NYU Langone Health in

HealthDay 12 August at 03.44 PM

Commonly Prescribed Antibiotics Linked to Cutaneous Adverse Drug Reactions

Sulfonamide antibiotics and cephalosporins are most strongly associated with serious cutaneous adverse drug reactions (cADRs), according to a study published online Aug. 8 in the Journal of the American Medical Association.Erika Y. Lee, M.D., from the University of Toronto, and colleagues explored the risk for serious cADRs associated w

HealthDay 09 August at 03.37 PM

Racial Differences Identified in Frequency of Biopsy for Psoriasis

There are racial differences in the frequency of skin biopsy for psoriasis, indicating diagnostic uncertainty, according to a research letter published online Aug. 7 in JAMA Dermatology.Fahad Ahmed, from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a cross-sectional study inv

HealthDay 08 August at 03.42 PM

ChatGPT Only Gets Diagnoses Correct Half of the Time

ChatGPT is not accurate as a diagnostic tool, but does offer some medical educational benefits, according to a study published online July 31 in&nbsp;PLOS ONE.Ali Hadi, from the Schulich School of Medicine and Dentistry at Western University in London, Ontario, Canada, and colleagues investigated ChatGPT’s diagnostic accuracy and utili

HealthDay 08 August at 11.41 AM

New Strain of Mpox Spreading in Africa Has CDC Concerned

U.S. doctors should be on the lookout for a more severe strain of mpox that is spreading widely in parts of Africa, federal health officials warned Wednesday.The&nbsp;alert,&nbsp;issued by the U.S. Centers for Disease Control and Prevention, came just hours after the World Health Org

HealthDay 06 August at 11.04 PM

Alopecia Tied to Higher Prevalence of Autoimmune, Psychiatric Comorbidities

Patients with alopecia areata (AA) have a higher prevalence of autoimmune and psychiatric comorbidities at time of diagnosis as well as a higher risk for new-onset autoimmune and psychiatric comorbidities after diagnosis, according to a study published online July 31 in&nbsp;JAMA Dermatology.Arash Mostaghimi, M.D., M.P.H., from Brigham

HealthDay 02 August at 10.52 PM

FDA Approves Leqselvi for Severe Alopecia

The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral selective inhibitor of the Janus kinases JAK1 and JAK2. In trials, the three most common adverse events were headache, acne, and nasopharyngitis.The approval was

HealthDay 01 August at 09.37 PM

FDA Warns Against Using Chemical Peels Without Professional Supervision

The U.S. Food and Drug Administration is warning that chemical peels should not be used without the supervision of a dermatologist or other trained professional."FDA is warning consumers not to purchase or use certain chemical peel skin products without appropriate professional supervision due to risk of serious skin injuries," the agency said

HealthDay 01 August at 04.11 PM

CDC Report Addresses Nonfinancial Access Barriers to Care in 2022

Nonfinancial access barriers to care represent a persistent problem in the United States, with more than 12 percent of adults reporting being too busy to go to a provider, according to a study published online Aug. 1 in the&nbsp;National Health Statistics Reports, a publication from the National Center for Health Statistics.Amanda E. N

HealthDay 01 August at 03.59 PM

Relatively High Frequency of Emergency Complications Seen for Dermatological Procedures

A relatively high proportion of dermatologists experience emergency complications during dermatological, surgical, or cosmetic procedures, according to a study published online July 20 in the Journal of Cosmetic Dermatology.Hilal Kaya Erdogan, M.D., from Eskişehir Osmangazi University in Turkey, and colleagues conducted a cross-section

HealthDay 30 July at 08.54 PM

Gen Z Perceives Atopic Dermatitis to Be More Severe

Generation Z (Gen Z) patients present with a higher subjective perception of atopic dermatitis severity than millennial generation patients, according to a study published online July 25 in the&nbsp;International Journal of Dermatology.Clara Ureña-Paniego, from the University of Granada in Spain, and colleagues compared the clinical se

HealthDay 29 July at 07.12 PM

Atopic Dermatitis Has Large Impact on Sexual Function Among Women

Most women with atopic dermatitis have impairment in sexual function, and about half consider that atopic dermatitis may influence their reproductive desire, according to a study published online June 11 in Acta Dermato-Venereologica.Juan-Angel Rodriguez-Pozo, from the Virgen de las Nieves University Hospital in Granada, Spain, and coll

HealthDay 29 July at 03.30 PM

Psoriasis, Psoriatic Arthritis Tied to Higher Risk of Polyneuropathy

Psoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in&nbsp;Muscle &amp; Nerve.Pietro E. Doneddu, M.D., from the IRCCS Humanitas Research Hospital in Milan, and colleagues evaluated the risk and features of peripheral neuropathy in patients with psor

HealthDay 26 July at 03.50 PM

Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen Sclerosus

Hydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the&nbsp;International Journal of Dermatology.Christeebella O. Akpala, from the Mayo Clinic in Rochester, Minnesota, and colleagues analyzed the demog

HealthDay 24 July at 03.23 PM

Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema

Use of oral corticosteroids for &gt;90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in&nbsp;JAMA Network Open.Yong Hyun Jang, M.D., Ph.D., from Kyungpook National University in Daegu, South Korea, and colleagues examined the association betwee

HealthDay 19 July at 10.52 PM

Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults

With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published online July 17 in JAMA Dermatology.Katelyn J. Rypka, from the University of Minnesota in Minneapolis, and colleagues examined differences in the lifetime

HealthDay 19 July at 03.42 PM

Dose Requirements for Glabellar Botulinum Toxin Higher in High-Sun Climate

To achieve maximal paralysis, patients injected with glabellar botulinum toxin may have significantly higher dose requirements in a high sun-exposure environment, according to a study published in the July issue of Plastic and Reconstructive Surgery.Kim L. Borsky, M.B.B.S., M.D., from the Stoke Mandeville Hospital in the United Kingdom,

HealthDay 18 July at 04.04 PM

Air Pollution Exposure Tied to New Psoriasis

Long-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in&nbsp;JAMA Network Open.Junhui Wu, Ph.D., from the Peking University School of Nursing in Beijing, and colleagues examined the association between long-term exposure to air pollution and psoriasis an

HealthDay 16 July at 10.52 PM

Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine

For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) or indirect inhibition (triptans), according to a research letter published online July 10 in JAMA Dermatology.Chris

HealthDay 12 July at 10.23 PM

CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections

Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues charact

HealthDay 12 July at 10.21 PM

More Women Than Men Experience Nonphysical Violence in Health Care Workforce

Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin

HealthDay 11 July at 10.11 PM

FDA Approves Zoryve for Atopic Dermatitis

The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a once-daily, steroid-free cream that the company says will be available at the end of July.The approval was based on resu

HealthDay 10 July at 04.06 PM

Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in Acne

Adherence to a Mediterranean diet incorporating eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces skin lesions and improves quality of life in patients with acne, according to a study published online July 10 in the Journal of Cosmetic Dermatology.Anne Guertler, M.D., from Ludwig Maximilian University in Munich, and

HealthDay 09 July at 03.45 PM

Rural Residents Continue to Have Higher Odds of Skin Cancer

Urban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the&nbsp;Journal of Drugs in Dermatology.Rachel R. Lin, from the University of Miami Miller School of Medicine, and colleagues used data from the Behavior Risk Factor Surveillance Survey (2018 to 2021) to compare th

HealthDay 05 July at 02.26 PM

Postpandemic Physician Revenue Recovery Varies by Specialty, Practice Type

Pandemic-associated physician revenue recovery in 2021 and 2022 varied by specialty and practice type, according to a study published in the July issue of&nbsp;Health Affairs.Ravi B. Parikh, M.D., from the University of Pennsylvania in Philadelphia, and colleagues assessed pandemic-related impact on physician revenue (2020 to 2022) and h

HealthDay 02 July at 04.01 PM

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in&nbsp;JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass

HealthDay 01 July at 03.16 PM

Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue

Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American Academy of Dermatology.Lea Nymand, from Bispebjerg Hospital and the University of Copenhagen in Denmark, and colleagues explored the characteristics of fatigue and it

HealthDay 01 July at 03.04 PM

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in Dermatology.Maria Daviti, M.D., from Aristotle University in Thessaloniki, Greece, and colleagues reported the real-life management of

HealthDay 25 June at 09.42 PM

Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus

For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine

HealthDay 24 June at 03.02 PM

Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma

For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random

HealthDay 20 June at 08.56 PM

2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months

From 2021 to 2022, there was a decrease in the percentage of adults who used telemedicine in the past 12 months, according to the June 20 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Jacqueline W. Lucas, M.P.H., and Xun Wang, from the National Center for Health Statistics in Hyattsvil

HealthDay 18 June at 09.11 PM

Approximately 7 Percent of U.S. Population Uninsured in 2023

In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from

HealthDay 18 June at 03.44 PM

Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect

Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive

HealthDay 18 June at 09.50 AM

Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to Expire

In a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h

HealthDay 14 June at 03.32 PM

No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab

There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma &amp; Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub

HealthDay 13 June at 10.58 PM

Health Care Spending Growth Projected to Outpace GDP to 2032

Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare &amp; Medicaid Services in Baltimore, and colleagues projected growth in national health expend

HealthDay 12 June at 03.05 PM

Adverse Effects of Medical Treatment Increasing Worldwide

The burden of adverse effects of medical treatment (AEMT) is increasing, with the proportion of all cases accounted for by the increasing rates seen in older adults, according to a study published online June 11 in BMJ Quality &amp; Safety.Liangquan Lin, from the Chinese Academy of Medical Sciences &amp; Peking University Medical Col

HealthDay 07 June at 03.33 PM

Isotretinoin Effective for Acne in Those Receiving Gender-Affirming Therapy

Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen

HealthDay 06 June at 10.28 PM

CDC Urges Clinicians to Remain on the Lookout for Mpox Virus Infections

Among emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Carl T. Berdahl, M.D., from Cedars-Sinai Medical Center in Los Angeles, and co

HealthDay 05 June at 03.28 PM

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc

HealthDay 03 June at 09.12 PM

9.6 Percent of Medical Visits Took Place Via Telehealth in 2021

In 2021, 9.6 percent of medical visits took place via telehealth, with a higher percentage seen for mental health visits, according to a research letter published online June 4 in the Annals of Internal Medicine.Sandra L. Decker, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and colleagues describe te

HealthDay 31 May at 03.46 PM

1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema

Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the&nbsp;American Journal of Clinical Dermatology.Lawrence F. Eichenfield, M.D., from the University of California San Diego, and colleagues asse

HealthDay 30 May at 04.04 PM

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b

MedScape 30 May at 07.18 AM

Most Chronic Wounds Not Managed by Dermatologists

"By examining national trends in patient visits and treatment, we may be able to better inform healthcare utilization for cutaneous wounds," Chandy said.

MedScape 30 May at 06.51 AM

Psoriasis Tied to Increased Risk for MACE Despite Statin Use

The finding "highlights the need for further research into tailored treatments for cardiovascular risk in psoriasis patients," Ana Ormaza Vera said.

MedScape 29 May at 11.10 PM

Study Addresses Racial/Ethnic Disparities in Psoriasis Rx

Black patients with psoriasis had the lowest rate of switching to another biologic therapy compared with other racial and ethnic groups, suggesting possible disparities in treatment patterns.

HealthDay 29 May at 09.17 PM

2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending

From 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro

MedScape 29 May at 03.36 AM

Dupilumab: Future Treatment for Pediatric Alopecia Areata?

Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with alopecia.

MedScape 29 May at 03.07 AM

Tapinarof Cream Effective For AD, Down to Age 2 Years

Results from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.

HealthDay 28 May at 03.08 PM

Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis

Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA Dermatology.Gun Min Youn, from the Stanford University School of Medicine in California, and colleagues conducted a retrospective cross-sectional analysis of the 2014 to

MedScape 27 May at 03.26 AM

Parental e-Cigarette Use May Increase AD Risk in Children

Parental e-cigarette use was associated with an increased risk for pediatric atopic dermatitis in a retrospective, cross-sectional analysis of US population data.

MedScape 27 May at 02.51 AM

Eczema Risk Increased in Older Adults on Antihypertensives

Use of antihypertensive drugs was associated with a small increase in the rate of eczematous dermatitis diagnoses in older adults, with varying risks with different classes.

HealthDay 24 May at 04.06 PM

Antihypertensives Linked to Eczematous Dermatitis in Seniors

Antihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine

MedScape 24 May at 06.28 AM

Study Reveals Diverse Skin Manifestations in Hemochromatosis

An iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, can help diagnose hemochromatosis.

MedScape 23 May at 06.32 AM

High-Stage cSCC: Outcomes Superior With Mohs vs WLE

"Our hope is that these findings provide additional data to support Mohs as the standard of care for primary surgical treatment of high-stage cSCC," the study's lead author said.

HealthDay 22 May at 03.50 PM

Global Life Expectancy, Disease Burden Set to Keep Improving

Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease (GBD) study, published in the May 18 issue of The Lancet.Stein Emil Vollset, M.D., M.P.H., and colleagues from the GBD 2021 Forecasting Collaborators provide a reference forecast and a

MedScape 22 May at 11.00 AM

Top Tools for Measuring AD in Clinical Practice Recommended

Consensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds.

MedScape 22 May at 04.53 AM

Home Phototherapy for Psoriasis: Optimizing Access

The ideal candidate "is averse to using systemic agents but whose disease is beyond the point where topical medicines alone will work," Craig A. Elmets, MD, said.

HealthDay 21 May at 10.56 PM

Acrochordons May Be Marker for Metabolic Disease in Children

In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.Rachel K. Greene, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a single-center retrospective cohort study of outpatient dermatology patients between Jan. 1, 20

MedScape 20 May at 11.57 PM

Study Finds Radiotherapy for NMSC in Dermatology Growing

There is persistent growth in eBT/SRT by a small but expanding proportion of general dermatologists.

HealthDay 20 May at 03.58 PM

Individuals With BAP1 Have High Rate of Nail Abnormalities

Individuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA Dermatology to coincide the annual meeting of the Society for Investigative Dermatology, held from May 15 to 18 in Dallas.Alexandra Lebensohn, from the Nat

MedScape 20 May at 03.03 AM

Chart Review Highlights Unique AD Features in Older Patients

More research is "needed to elucidate the unique features of elderly AD in pathophysiology and optimal treatments," the study authors wrote.

MedScape 19 May at 11.07 PM

Study Identifies Several Onychomycosis Risk Factors

Tinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in patients with onychodystrophy.

MedScape 16 May at 09.26 AM

Skin Tags Linked to Metabolic Syndrome in Children

Acrochordons (skin tags) in children and adolescents may serve as a marker for metabolic diseases.

MedScape 16 May at 09.23 AM

Wits of Pediatric Dermatologists Pitted Against ChatGPT

Overall, version 4.0 of the AI tool performed better than version 3.5.

MedScape 16 May at 05.10 AM

Tranexamic Acid Injection Reduces Bleeding After Mohs

Adverse effects associated with using the antifibrinolytic were rare.

HealthDay 15 May at 07.29 PM

Non-Hispanic Black Melanoma Patients Present With Advanced Disease

Non-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study published in the May issue of the Journal of Surgical Oncology.Jessica A. Steadman, M.B.B.S., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined fe

HealthDay 15 May at 03.45 PM

AACR Delivers Report on Disparities in Cancer Progress

In its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un

MedScape 14 May at 10.13 AM

US Study Delves Into Risk Factors for Melasma

Exposure to hormones, hyperpigmenting drugs, and multiparity increased risk for melasma across different racial groups in a US study of a diverse population.

HealthDay 13 May at 10.34 PM

Physicians With Disabilities May Experience Depersonalization

Physicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their peers without disabilities, according to a research letter published online May 9 in&nbsp;JAMA Network Open.Lisa M. Meeks, Ph.D., from the University of Michigan Medical School in Ann Arb

HealthDay 13 May at 03.50 PM

Study Identifies Factors Associated With Hydroxychloroquine Retinopathy

Factors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney disease stage 3 or greater, according to a study published online May 9 in JAMA Network Open.April M. Jorge, M.D., from Massachusetts General Hospital in Boston, and colleagues identified

HealthDay 13 May at 03.46 PM

Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights

Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment, according to a study published online April 17 in the Journal of Personalized Medicine.Georgiana Strugariu, from "Grigore T. Popa" University of Medicine and Phar

MedScape 13 May at 09.58 AM

Patient Preferences Drive Treatment Options for Early HS

Most ongoing trials of HS treatments are for moderate to severe disease, Dr Jennifer L. Hsiao said.

MedScape 13 May at 08.59 AM

Reimbursement Rates for Mohs Surgery Lag Behind Inflation

Healthcare delivery costs are rising, but there has been a lag in the increase in dermatologic procedure reimbursement rates.

MedScape 13 May at 07.29 AM

Experts Share Practical Tips for Diagnosing Mild HS

"Early HS can mimic an intense folliculitis or furuncles that can sometimes be caused by Staphylococcus infections," Sayed said.

MedScape 13 May at 06.18 AM

Kids With Skin Diseases Face Stigma, Reduced Quality of Life

Physicians' assessment of disease severity and visibility may underestimate the disease's effects on the patient, data suggested.

HealthDay 10 May at 12.42 PM

Cyberattack Cripples Major U.S. Health Care Network

Ascension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our electronic health records system, MyChart (which enables patients to view their medical records and communicate with their provid

MedScape 10 May at 06.19 AM

Immunosuppression Risk Factor for Poor cSCC Outcomes

In contrast to earlier findings, immunosuppression was an independent risk factor for disease-specific death and major poor outcomes.

MedScape 09 May at 08.55 AM

Adalimumab Improves Blood Parameters in Patients With HS

Treatment with adalimumab was associated with improvements in common hematologic abnormalities in patients with hidradenitis suppurativa, particularly in responders.

MedScape 09 May at 08.47 AM

SDM in Pediatric Dermatology: Step Approach Recommended

A pediatric dermatologist proposes a four-step approach to using shared decision-making (SDM) when caring for children and adolescent patients with acne and other skin conditions.

MedScape 09 May at 06.33 AM

Evidence Accumulating on Viral Cause of Cutaneous Granulomas

Of the cases accruing in the United States and elsewhere, most but not all were linked to inborn errors of immunity.

HealthDay 08 May at 03.29 PM

Trifarotene Plus Skin Care Beneficial for Acne Vulgaris

Trifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International Journal of Dermatology.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medical College in New York City, and colleagues conducted a phase IV

HealthDay 08 May at 03.07 PM

Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk

Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published online April 24 in the&nbsp;Journal of Allergy and Clinical Immunology.Courtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues e

MedScape 08 May at 04.39 AM

IPC Develops Consensus on Generalized Pustular Psoriasis

The IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical considerations to speed treatment of this potentially life-threatening condition.

MedScape 07 May at 08.28 AM

Many Drugs Linked to Pediatric SJS-TEN, WHO Data Show

Antiepileptic and anti-infectious agents were the most common classes tied to SJS-TEN.

MedScape 07 May at 05.02 AM

Some Patients More Likely to Get Opioids After Mohs Surgery

Certain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use.

MedScape 07 May at 04.19 AM

Rates of Emotional and Physical Stress High in Mohs Surgeons

Almost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury.

MedScape 06 May at 03.58 AM

Correct Dx of Cancer Treatment Skin Effects Evaluated

The survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions.

MedScape 06 May at 03.35 AM

Review Addresses Skin Manifestations of Cystic Fibrosis

A review covers the various skin manifestations seen in patients with CF, which include those related to the disease itself, and those associated with treatments for CF.

MedScape 06 May at 12.01 AM

Many Patients With Advanced MCC Not Receiving Immunotherapy

Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.

HealthDay 02 May at 03.37 PM

Algorithm From EHR Can ID Common Variable Immunodeficiency Disease

A machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to a study published in the May 1 issue of Science Translational Medicine.Due to the low prevalence and extensive heterogeneity in CVID phenotypes, resulting in delayed diagnoses and tre

MedScape 02 May at 07.17 AM

Mpox Presentation Compared in Racial, Ethnic Groups

A retrospective review that may be the first to examine the topic found differences in mpox symptoms between White non-Hispanic patients and patients of color.

MedScape 02 May at 07.10 AM

ILD Not Increased With MTX in Patients With Dermatomyositis

Treatment with methotrexate was not associated with an increased risk for interstitial lung disease (ILD) in patients with dermatomyositis.

HealthDay 30 April at 04.12 PM

Stigma Affects Quality of Life in Children With Chronic Skin Conditions

Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and col

MedScape 30 April at 09.07 AM

Heat-Based Wrinkle Treatment Holds up With Facial Anesthesia

Surface anesthesia prior to thermomechanical fractional injury therapy for wrinkles around the eyes provided adequate comfort, with positive treatment outcomes, a small study found.

MedScape 30 April at 03.39 AM

Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review

A decision on approval is expected in the fourth quarter of 2024.

MedScape 29 April at 05.54 AM

Children With Chronic Skin Disorders Face Substantial Stigma

Healthcare professionals should be aware of the possibility of stigmatization and bullying when assessing the social and mental health of children and adolescents with chronic skin disorders.

MedScape 26 April at 07.49 AM

Prurigo Nodularis Associated With Elevated CV Risks

"The potential risk of subsequent cardiovascular disease should be considered in the care of patients with PN," according to the study authors.

MedScape 25 April at 09.28 AM

FDA Seeks More Information About RDEB Rx Under Review

Pz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds.

HealthDay 24 April at 07.53 PM

Tobacco Smoking Reduces the Odds of Psoriasis Improvement

Tobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases.Yan Qiang, from the School of Medicine at Tongji University in Shanghai, and colleagues explored the influence of smoking on treatment efficacy in patients with psoriasis. The

MedScape 24 April at 03.16 AM

Erenumab Reduces Flushing and Erythema in Rosacea

A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.

HealthDay 23 April at 03.53 PM

Atopic Dermatitis Negatively Impacts Mental Health

Atopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 in&nbsp;Dermatitis.Jessica K. Johnson, M.P.H., from the National Eczema Association in San Rafael, California, and colleagues evaluated patient-reported MH symptoms and their c

MedScape 22 April at 08.32 AM

Hair Loss: Experts Provide Recommendations on Oral Minoxidil

The authors "identified a need for expert-based guidelines for prescribing and monitoring LDOM use in hair loss patients."

MedScape 22 April at 06.12 AM

Neuromodulators: Rapid-Onset Option, Other Emerging Trends

Expect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, and rosacea to gain a foothold in dermatology practices, one expert says.

MedScape 22 April at 03.32 AM

Study Shows Faster Recovery, Less Pain With 2910-nm Laser

A small study of the 2910-nm erbium-doped fluoride glass fiber laser for facial ablation showed that patients had faster recovery times and less pain than with conventional lasers.

MedScape 22 April at 03.22 AM

Does AD Severity Affect Growth in Children?

An analysis evaluated growth in a study of 1326 children with AD younger than 12 years.

HealthDay 19 April at 03.41 PM

Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome

Cutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease.Xiang Li Tan, M.B.B.S., from St. George's University Hospitals NHS Foundation Trust in London, and colleagues conducted a systematic review to examine the prevalence, types, and prognos

MedScape 19 April at 08.52 AM

Less PIH After Modified Laser Rx for Lentigines Reported

A 532-nm picosecond laser with fractional-beam microlens array to treat solar lentigines resulted in a lower hyperpigmentation rate in patients with darker skin types, vs the full-beam approach.

MedScape 19 April at 04.58 AM

Registry Gives Snapshot of Cosmetic Procedure-Related AEs

A registry of adverse events from dermatologic procedures found that blistering, hypopigmentation, scars, and burns are the most common complications from laser and energy devices.

MedScape 18 April at 06.44 AM

Laser, Light Treatments Effective for PCOS-Related Hirsutism

Laser and light hair treatments, with and without other treatments, improve hirsutism and related psychological measures in women with PCOS.

MedScape 18 April at 02.59 AM

Weekly Laser Treatment Promising for Port-Wine Birthmarks

Once-weekly PDL treatment in infants led to near-total or total clearance of PWB and was well-tolerated in 10 infants, suggesting further investigation of the reduced treatment interval of 1 week.

HealthDay 17 April at 04.00 PM

Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing

The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA Dermatology.Nita K.F. Wienholtz, M.D., Ph.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleag

MedScape 17 April at 09.37 AM

Study Evaluates Time of Lung Disease Onset With Rare DM

Rapidly progressive interstitial lung disease was diagnosed in almost half of the patients with MDA5 antibody-positive dermatomyositis.

MedScape 16 April at 02.08 PM

CDC Investigating Reactions Linked to Counterfeit 'Botox'

Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism.

HealthDay 16 April at 11.40 AM

CDC Warns of 19 Cases of Botched Botox Shots in 9 States

Counterfeit or mishandled Botox shots have triggered harmful reactions in 19 people in nine states, U.S. health officials warned Monday.In its alert, the U.S. Centers for Disease Control and Prevention said nine people had been hospitalized and four we

MedScape 16 April at 06.17 AM

Survey Highlights Impact of Cosmetic-Procedure Complications

Study finds that people who have complications after cosmetic procedures have higher rates of depression, anxiety, and other mental health issues than before the procedures.

MedScape 16 April at 06.05 AM

Counterfeit Neurotoxin Investigations Prompt Call for Action

The American Society for Dermatologic Surgery Association emphasized the risks for medical procedures in unlicensed settings.

MedScape 16 April at 05.35 AM

Review Evaluates Data on Injectables in Skin of Color

In this literature review, researchers found that neuromodulators and dermal fillers are useful and safe in SOC populations, although more data are needed in some groups.

MedScape 15 April at 08.49 AM

Survey Highlights Benefits of Pediatric Derm-Rheum Clinics

Pediatric dermatology-rheumatology combined clinics improve patient outcomes and satisfaction.

MedScape 15 April at 02.03 AM

Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors

Reports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare.

MedScape 15 April at 01.34 AM

Alopecia Areata: Late Responses to JAK Inhibitors Reported

Response curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting.

MedScape 12 April at 09.42 AM

Extension Data Reported for Chronic Hand Eczema Treatment

Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.

MedScape 12 April at 08.58 AM

Topical Vs Oral Minoxidil for AGA: Which Is More Effective?

Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil.

MedScape 12 April at 08.25 AM

What's Behind Long-Term Antibiotic Prescribing for Acne?

"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview.

HealthDay 10 April at 06.15 PM

Study Identifies Factors That Affect Antibiotic Prescribing for Acne

Multiple salient factors affect long-term antibiotic prescribing practices for acne, according to a study published online April 3 in JAMA Dermatology.Ronnie A. Festok, from the Emory University School of Medicine in Atlanta, and colleagues conducted a qualitative study assessing data collected from stakeholders (dermatologists, inf

HealthDay 10 April at 03.57 PM

Bioactive Retinol Efficacious for Improving Signs of Photoaging

Stabilized bioactive retinol is efficacious for improving signs of photoaging, without causing major irritation, according to a study published in the April issue of the Journal of Drugs in Dermatology.Patricia Farris, M.D., from Tulane University School of Medicine in New Orleans, and colleagues examined the comprehensive efficacy

MedScape 10 April at 07.46 AM

New Tool Could Help Screen Patients for Zoom Dysmorphia

Individuals with zoom dysmorphia tend to scrutinize their facial features and fixate on what they think needs to improve and feel pressured to appear perfect before virtual meetings.

MedScape 10 April at 05.22 AM

Childhood Atopic Dermatitis Linked to IBD Risk

A prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease.

MedScape 09 April at 03.18 AM

Expert Recommends Phased Approach For Delusional Infestation

Phase 4 involves initiating therapy, which includes demonstrating empathy by reflecting on the detrimental effects of the patient's reported sensations on their quality of life.

MedScape 09 April at 12.35 AM

Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study

Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.

HealthDay 08 April at 10.30 PM

FDA Approves New Antibiotic for Three Indications

The U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream infections, adults with acute bacterial skin and skin structure infections, and adult and pediatric patients (age 3 months

MedScape 05 April at 08.16 AM

Transplant Recipients: Consider Skin Cancer, Infection Risks

Recent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients.

MedScape 05 April at 03.22 AM

Medicare IHC Claims With Melanoma Dxs Increased, Study Finds

With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.

MedScape 05 April at 02.17 AM

FDA Accepts Application for a New HS Treatment

Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

MedScape 04 April at 06.39 AM

Review Describes Semaglutide-Associated Skin Effects

Alopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug.

HealthDay 03 April at 03.45 PM

Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma

Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.Lauren Banner, from Thomas Jefferson University in Philadelphia, and colleagues used the Surveillance, Epidemiolo

MedScape 03 April at 06.01 AM

Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus Trial

Rilzabrutinib did not meet primary or secondary endpoints in the phase 3 PEGASUS trial of patients with pemphigus vulgaris or foliaceus.

MedScape 03 April at 03.29 AM

Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.

MedScape 03 April at 02.33 AM

Intralesional Wart Treatments Are Among Options to Consider

Alternatives to SA and cryotherapy for warts may be helpful "for patients who have failed traditional therapies or have a contraindication to the usual go-tos," said Dr Jennifer Adams.

MedScape 02 April at 07.41 AM

JAK Inhibitors for Vitiligo: More Skin Response Over Time

Two JAK inhibitors for non-segmental vitiligo showed better skin clearance in phase 2b trial extensions — ritlecitinib plus twice-weekly doses of UVB light and upadacitinib.

MedScape 01 April at 01.39 AM

Tooth Enamel Disorder Is a Feature of Kindler EB

Study found that hypoplastic pitted amelogenesis imperfecta is among the oral manifestations of Kindler epidermolysis bullosa, underscoring the need for early and sustained dental care.

MedScape 01 April at 01.16 AM

Rate of Malignancy Low in Pediatric LM

Pediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy.

HealthDay 29 March at 03.14 PM

U.S. Doctors Received Industry Payments of $12.13 Billion From 2013 to 2022

U.S. physicians received $12.13 billion from industry from 2013 to 2022, according to a research letter published online March 28 in the Journal of the American Medical Association.Ahmed Sayed, M.B.B.S., from Ain Shams University in Cairo, and colleagues examined the distribution of payments within and across specialties and the medica

HealthDay 29 March at 11.42 AM

High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA Warns

Some pain-relieving skin products contain potentially harmful doses of the numbing agent lidocaine and should be avoided, the U.S. Food and Drug Administration warns.These creams, gels, sprays and soaps are marketed for topical use to relieve the pain of cosmetic procedures like microdermabrasion, laser hair removal, tattooing and <a href="http

MedScape 27 March at 12.24 PM

FDA Warns Consumers Against Using Some Topical Analgesics

The warning applies to unapproved products illegally marketed for topical use to relieve pain before, during, or after cosmetic procedures.

MedScape 26 March at 06.37 AM

Hair-Straightening Products Entail Acute Kidney Failure Risk

Products containing glyoxylic acid were associated with the accumulation of calcium oxalate crystals in the kidneys.

HealthDay 25 March at 03.55 PM

Social Media + Photo-Editing Apps Tied to Higher Interest in Cosmetic Procedures

Time spent on social media and use of photo-editing applications contribute to the desire to undergo a cosmetic procedure, according to a study recently published in the&nbsp;Journal of Clinical and Aesthetic Dermatology.Iman F. Khan, M.D., M.P.H., from Boston University, and colleagues surveyed 175 adults visiting an outpatient dermat

HealthDay 22 March at 10.09 PM

Four in 10 Adults Choose Telemedicine Visits

Many patients, including those with the greatest care needs, choose telemedicine even when in-person visits are available, according to a study published online March 22 in&nbsp;JAMA Network Open.Eva Chang, Ph.D., M.P.H., from Advocate Health in Milwaukee, Wisconsin, and colleagues assessed patient characteristics associated with telem

HealthDay 22 March at 03.58 PM

Survey Assesses Perspectives on Patient Image Use in Dermatology

Most patients report an increase in trust in the quality of their medical care if asked for permission to use their images for research or education, according to a research letter published online March 13 in JAMA Dermatology.Trina Salvador, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a s

HealthDay 22 March at 03.56 PM

Physicians Concerned About Private Equity's Impact on Health Care

Physicians express largely negative views about the impact of private equity (PE) on the health care system, according to a research letter published online March 11 in&nbsp;JAMA Internal Medicine.Jane M. Zhu, M.D., from Oregon Health and Science University in Portland, and colleagues conducted a survey to assess physicians' views towa

MedScape 22 March at 01.58 AM

Acne Products With Benzoyl Peroxide Under Scrutiny

In a citizen's petition, Valisure asked the FDA to recall acne products with benzoyl peroxide, stirring debate.

HealthDay 21 March at 10.59 PM

Life Expectancy Increased From 2021 to Reach 77.5 Years in 2022

Life expectancy increased to 77.5 years in 2022, while the age-adjusted rate of drug overdose deaths increased from 2002 to 2022 but did not change from 2021 to 2022, according to two March data briefs published by the National Center for Health Statistics.Kenneth D. Kochanek, from the National Center for Health Statistics in Hyattsville, Mar

MedScape 21 March at 09.16 AM

AI in Dermatology: Consider Its Limitations and Problems

Artificial intelligence is coming to clinical dermatology, but its enormous promise for improving the lives of patients and physicians will depend on addressing the expected problems.

MedScape 21 March at 07.58 AM

Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy

A study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine.

MedScape 20 March at 01.03 PM

Study Evaluates Acne Risk With Reversible Contraception

In the study, 28.5% of the adolescents and young adults experienced worsening acne after insertion of a progestin-only long-acting reversible contraceptive, and 17% reported acne as a new concern.

MedScape 20 March at 07.14 AM

FDA Expands Approval of Treatment for GPP

Spesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults.

HealthDay 19 March at 11.05 PM

American Academy of Dermatology, March 8 to 12

The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in dermatology. The conference highlighted recent advances in the diagnosis and management of d

HealthDay 19 March at 03.42 PM

AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in Alopecia

For adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Brett King, M.D., Ph.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues reported po

MedScape 19 March at 07.48 AM

Roflumilast Cream Quickly Improved AD in Children, Ages 2-5

Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of "clear" or "almost clear" plus a two-grade improvement from baseline at week 4.

HealthDay 18 March at 03.55 PM

AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis

Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medicine in New York Ci

HealthDay 18 March at 03.52 PM

AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia

MONDAY, March 18, 2024 (HealthDay News) --&nbsp;Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Rodney D. Sinclair, M.D., from the University of Me

MedScape 18 March at 05.46 AM

Tips on Managing Acne in Transmasculine Patients

Testosterone therapy can exacerbate symptoms, and other factors are important to consider, expert said.

HealthDay 15 March at 03.25 PM

AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air Pollution

Short-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Alex Ha, from the University of California, San Francisco, and colleagues conducte

HealthDay 15 March at 03.21 PM

AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe Psoriasis

FRIDAY, March 15, 2024 (HealthDay News) --&nbsp;Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Bruce Strober, M.D., Ph.D., from the Yale Sc

MedScape 15 March at 11.40 AM

Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks

The encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis.

MedScape 15 March at 05.49 AM

Most Baby Cleansers Are Not 'Allergen-Free,' Study Finds

A recent study demonstrated that 94% of top-selling baby cleansers contain allergens, despite having hypoallergenic claims.

HealthDay 14 March at 12.04 PM

HHS Opens Investigation Into UnitedHealth Cyberattack

Following a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private patient data, the U.S. Department of Health and Human Services said Wednesday it has begun an investigation into the incident.In a&nbsp;<a href="https://www.hhs.gov/about/news/2024/03/13/h

MedScape 14 March at 09.07 AM

Major Responses Seen for Cicatricial and Total Hair Loss

Two oral therapies targeted at kinase pathways produced meaningful responses in patients with severe types of alopecia in late-breaking studies at the American Academy of Dermatology.

MedScape 14 March at 06.42 AM

Florida Bill Addresses Coverage of Skin Cancer Screening

Some 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis.

HealthDay 13 March at 12.05 PM

Cyberattack Leaves Health Care Providers Reeling Weeks Later

Following a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day.That <a href="https://www.ama-assn.org/press-center/press-releases/cyberattack-jeopardizes

MedScape 13 March at 07.06 AM

2024 AAD Acne Guidelines: Newer Therapies Join Old Standbys

A coauthor of the new recommendations highlights updated advice and comments on worrisome benzene news.

HealthDay 12 March at 10.49 PM

Atopic Dermatitis in Children Tied to Learning, Memory Difficulties

Pediatric atopic dermatitis (AD) is&nbsp;associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with neurodevelopmental comorbidities, according to a study published online March 6 in&nbsp;JAMA Dermatology.Emily Z. Ma, from the University of Maryland School of Medicine

MedScape 12 March at 04.54 PM

Lebrikizumab Found Effective for Patients With AD, SOC

Interim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI.

MedScape 11 March at 05.36 PM

Study Eyes Effect of Maternal HS on Outcomes in Offspring

The study population included nearly 1.3 million children born in Quebec, Canada, over a 16-year period.

MedScape 10 March at 07.53 PM

Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control

Both an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies.

MedScape 10 March at 05.01 PM

Home- and Office-Based Phototherapy for Psoriasis Compared

The multicenter LITE trial included 783 patients at 42 sites in the United States.

MedScape 10 March at 02.29 PM

During Pregnancy, Many Drugs Safe for Skin Infections

Several drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues.

MedScape 09 March at 04.07 PM

New NCCN Melanoma Guidelines Capture Evolving Best Practice

NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.

MedScape 09 March at 02.41 PM

Novel Drug Shows Promise for Hidradenitis Suppurativa

The findings suggest that Bruton's tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS.

MedScape 08 March at 06.28 PM

Flexibility Advised for Patients With Personality Disorders

Up to 15% of the general population is affected by a personality disorder, according to dermatologist, Mio Nakamura, MD.

HealthDay 08 March at 04.59 PM

AAD: Concerns Noted Relating to Use of AI Dermatology Apps

There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published online March 7 in JAMA Dermatology to coincide with the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Shannon Wongvibulsin

MedScape 08 March at 04.07 PM

Anti-DEI Petition Sparks Conflict at Nat'l Derm Meeting

A controversial proposal to end the American Academy of Dermatology diversity programs will be considered at the group's annual meeting starting today.

MedScape 08 March at 08.01 AM

Sulfites Selected as ACDS Allergen of the Year

Experts lobby for increased inclusion of sulfites in patch test panels.

MedScape 08 March at 06.14 AM

Psoriasis Study Shows a Path for Considering US Drug Costs

Only three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations.

HealthDay 07 March at 02.00 PM

Carcinogen Benzene Can Form in Some Acne Treatments: Report

Some acne treatments may banish blemishes but carry hidden dangers: A new report reveals high levels of the carcinogen benzene can form in products that contain the zit-fighting ingredient benzoyl peroxide.According to the new&nbsp;report from

MedScape 07 March at 07.06 AM

Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?

The analysis included children aged 17 years or younger without intellectual disability or autism.

HealthDay 06 March at 04.38 PM

Skin of Color Underrepresented in AI Programs in Dermatology

Challenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets, according to research published online March 6 in the International Journal of Dermatology.Rebecca Fliorent, from the Rowan-Virtua School of Osteopathic Medicine in St

MedScape 06 March at 01.53 AM

New Indication Approved for Juvéderm

In a randomized, controlled trial, 59% of adults reported experiencing at least one treatment site response.

HealthDay 06 March at 12.00 AM

Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp Psoriasis

For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt in Germany, and colleagues conducted a multicenter, double-blind, vehicle-controlled phase 3 trial to examine the e

HealthDay 06 March at 12.00 AM

Higher Use of Health Care Portal Seen During COVID-19 Pandemic

Health care portal use was higher during the COVID-19 pandemic, according to a study published online Feb. 29 in JAMA Network Open.Esther Yoon, Ph.D., M.P.H., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues examined the prevalence of health care portal use before, during, and after the most re

MedScape 04 March at 10.21 PM

FDA Approves Another Neurotoxin for Frown Lines

The product has been sold in more than 50 countries, the company says.

MedScape 03 March at 11.01 PM

Patient-Reported Outcomes Important in Cutaneous GVHD: Study

The study results "highlight the importance of patient-reported outcomes in measuring this disease," the study's lead author said.

MedScape 01 March at 02.06 AM

Review Highlights Evidence of Climate Change Effects on AD

Atopic dermatitis "could serve as a case study for climatic impacts on health," the authors emphasized in their paper.

MedScape 29 February at 11.18 PM

Study Finds No Increased Cancer Risk With Spironolactone

Over 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone.

MedScape 29 February at 12.45 AM

What’s The Incidence Rate of a Second Primary Melanoma?

The findings may have potential implications for more personalized surveillance of patients with melanoma, the authors said.

HealthDay 27 February at 04.59 PM

Delayed Melanoma Care During Pandemic Proved Costly

Delays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in&nbsp;JAMA Network Open.Lara V. Maul, M.D., from University Hospital of Basel in Switzerland, and colleagues examined the consequences associa

MedScape 27 February at 07.38 AM

What Drives Fatigue in Psoriasis and PsA?

Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.

HealthDay 26 February at 05.02 PM

Observed Rates of Cancer Diagnoses Lower Than Expected in Pandemic

During the COVID-19 pandemic, cancer diagnoses were lower than expected, according to a study published online Feb. 22 in JAMA Oncology.Todd Burus, from the Markey Cancer Center at the University of Kentucky in Lexington, and colleagues conducted a population-based cross-sectional analysis of cancer incidence trends using data on cases

MedScape 26 February at 01.47 AM

TikTok Info on Infantile Hemangiomas Suspect: Study

In a cross-sectional study of the social media platform, researchers analyzed 50 videos on the topic.

MedScape 26 February at 12.34 AM

Biologic Treatment for Psoriasis Linked to Lower Mortality

Evidence to support the hypothesis that the use of systemic immunomodulatory agents for psoriasis "quenches systemic inflammation and potentially improves" survival is limited, investigators said.

HealthDay 23 February at 11.30 PM

Level of Burnout Higher for Women in Health Care Occupations

Women in health care occupations endure a significantly higher level of stress and burnout than men, according to a study published online Feb. 21 in Global Advances in Integrative Medicine and Health.Viktoriya Karakcheyeva, M.D., from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colle

MedScape 23 February at 12.38 PM

EMA Approves Tx for Psoriasis and Other Autoimmune Disorders

The biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009.

MedScape 23 February at 09.00 AM

'Superclinic' Powers Through Skin Cancer Referrals

One hospital's experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery.

MedScape 23 February at 01.34 AM

Longer IV Ertapenem Course Beneficial for Recalcitrant HS

2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning.

HealthDay 22 February at 12.17 PM

Jill Biden Announces $100 Million for Research on Women's Health

First Lady Jill Biden on Wednesday announced $100 million in federal funding to fuel research into women's health.“We will build a health care system that puts women and their lived experiences at its center,” Biden said in a White House <a href="https://www.whitehouse.gov/briefing-room/speeches-remarks/2024/02/21/remarks-as-prepared-for-deliv

MedScape 22 February at 08.13 AM

One-a-Day Pill for Alopecia Recommended for NHS Use

NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.

HealthDay 21 February at 04.01 PM

Clinical Markers Improve With IV Ertapenem for Hidradenitis Suppurativa

Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.Avigdor Nosrati, M.D., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a retrospective rev

HealthDay 21 February at 01.45 PM

This Election Year, Health Care Costs Top Voter Concerns: Poll

Unexpected medical bills and high health care costs are dominating an election where kitchen table economic problems weigh heavily on voter’s minds, a new KFF poll has found.Voters struggling to pay their monthly bills are most eager to hear presidential candidates talk about economic and health care issues, according to the latest KFF Health

MedScape 21 February at 02.12 AM

Nemolizumab Being Reviewed for AD, Prurigo Nodularis

For prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review.

MedScape 20 February at 10.49 PM

What Skin Manifestations Are Associated With Pediatric IBD?

Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common.

HealthDay 20 February at 04.26 PM

Amtagvi Approved by the FDA for Treatment of Advanced Melanoma

Amtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer."The approval of Amtagvi offers hope to those with advanced melanoma who have progressed following initial standard-of-care therapies

HealthDay 17 February at 12.00 AM

Expanded Use of Xolair to Treat Food Allergies Approved by the FDA

The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other anaphylaxis rescue remedies, the agency stressed. Instead, "Xolair is intended for repeated use to reduce the risk of allergic re

HealthDay 16 February at 04.32 PM

Deep Learning Improves Diagnostic Accuracy for Skin Diseases

Deep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine.Matthew Groh, Ph.D., from the Northwestern University Kellogg School of Management in Evanston, Illinois, and colleagues presented results from a study involving 389 board-certified dermatol

MedScape 16 February at 12.53 AM

Cellulite: Outcomes 1 Year After Noninvasive Treatment

The findings build on results from a 12-week study of the device, which the investigators said "induces physical shearing of fibrous septa through rapid acoustic pulses."

MedScape 16 February at 12.02 AM

Tapinarof Under FDA Review for Treating Atopic Dermatitis

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.

HealthDay 15 February at 04.42 PM

FDA Approves Aurlumyn for Severe Frostbite

Aurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation."This approval provides patients with the first-ever treatment option for severe frostbite," Norman Stockbridge, M.D., director of the Division of Cardiol

HealthDay 14 February at 11.06 PM

Study Looks at Access to U.S. Burn Centers Using 2019 Data

Access disparities to burn centers persist, with lower access in the South and West and for those with lower income, according to a research letter published online Feb. 14 in JAMA Surgery.Dong Gi Hur, from the Stanford School of Medicine in California, and colleagues characterized access to American Burn Association (ABA)-verified a

MedScape 14 February at 02.14 AM

Lab Testing in Patients on Immunomodulators Falls Short

Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.

MedScape 13 February at 11.11 PM

Tinea Capitis Management in Kids Varies, Survey Finds

Respondents included 56 members of the Pediatric Dermatology Research Alliance.

HealthDay 12 February at 04.17 PM

Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies

The association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities, according to a study published online Feb. 1 in eClinicalMedicine.Yeon Mi Hwang, from the Institute for Systems Biology in Seattle, and colleagues conducted a retrospectiv

HealthDay 12 February at 04.13 PM

Smoking Linked to Melanoma-Associated Death in Early-Stage Melanoma

For patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 in JAMA Network Open.Katherine M. Jackson, M.D., from the Saint John's Cancer Institute at Providence Saint John's Health Center in Santa Monica, California, and col

MedScape 09 February at 05.04 PM

Tools on the Horizon for Managing Posttransplant cSCC Risk

Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients.

HealthDay 09 February at 04.56 PM

Health Care Costs, Resource Utilization Increased for Vitiligo Patients

Patients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of Investigative Dermatology.Khaled Ezzedine, M.D., from Henri Mondor University Hospital in Créteil,&nbsp;France, and colleagues conducted a retrospective cohort analysis

MedScape 09 February at 04.42 PM

Analysis Finds Allergens in Many Topical Scar Products

Of the 156 products identified, most were gels, creams, or oils.

MedScape 09 February at 05.44 AM

Spitz Nevi: An Expert Shares Tips for Diagnosis, Management

Dr Caroline Piggott provides her perspective on dermoscopy, shave vs punch biopsies, and treatment.

MedScape 09 February at 02.26 AM

Periocular Melanoma Still Rare, But May Be Increasing

Pain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants.